Join us on March 16th from 1:00pm – 2:00pm ET for a webinar titled, “Pharmacokinetics 101: Introducing PK Concepts & NCA.” Nuventra’s Vice President of Clinical Pharmacology & Pharmacokinetics, Mark Bush, Ph.D., provides an overview of Pharmacokinetics (PK) and Noncompartmental Analysis (NCA) fundamentals. This will be a replay of our PK 101 webinar with a live Q&A session following the presentation.
PK analysis, including NCA, helps to characterize how a drug enters, distributes, and is removed from the body. PK data contribute to much of what is included in a drug label. This information can be applied to help us understand key aspects of a drug (e.g., optimal dosing regimen, drug interactions, and sources of variability in safety or efficacy) and can guide decision-making throughout the drug development process.
At the end of this webinar, attendees should have a better understanding of:
- PK and NCA fundamentals
- Routes of administration
- Key NCA parameters
- Areas under the curve
- PK parameters derived from AUC